JULIE B RHODES
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner HOUMA, LA NPI 1790769628
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner LA Acerta Pharma LLC All categories
General Payments — all program years on this page
$3,254.69
- Category: General Payments
- Program years: PY2021–2024
- Record count: 71
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $407.90 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $407.90 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $237.90 | 3 |
| Novo Nordisk AS | $92.08 | 1 |
| ABIOMED | $30.01 | 1 |
| ABBVIE INC. | $17.72 | 1 |
| Abbott Laboratories | $16.13 | 1 |
| PFIZER INC. | $14.06 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100634455 | Novo Nordisk Inc | $92.08 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104387175 | AstraZeneca Pharmaceuticals LP | $29.05 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105568629 | AstraZeneca Pharmaceuticals LP | $83.90 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105738001 | AstraZeneca Pharmaceuticals LP | $124.95 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1108080144 | ABBVIE INC. | $17.72 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125275779 | Abbott Laboratories | $16.13 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131611240 | PFIZER INC. | $14.06 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142197797 | ABIOMED | $30.01 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.